BCRX (BioCryst) Forward P/E Multiple
The forward P/E of BioCryst (BCRX) visualizes the projected stock value relative to expected earnings, with the 13.50 value serving as the baseline for the current valuation. BioCryst management enjoys confidence following the successful launch of its core product. Growth is driven by the expansion of Orladeyo and new developments. High margins are achieved through patents on unique tablet forms for treating rare pathologies.
Analytical breakdowns for BioCryst
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
BCRX - Net Financial Result|Expected Profit BioCryst|BCRX - Market Cap to Earnings|Forward P/E Multiple BioCryst Pharmaceuticals Inc|BCRX - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioCryst Pharmaceuticals, Inc.|BCRX - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months BioCryst|BCRX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months biocryst.com|BCRX - Expected net earnings per share growth this year|Expected earnings per share growth for next year BioCryst
Summary company analytics:BioCryst Pharmaceuticals
BioCryst (BCRX) generates a stable cash flow through lifelong therapy for rare diseases. The forward P/E ratio compares the current market value of the stock with the company's current net income forecasts. This metric determines the extent to which an investor is overpaying for the business's expected earnings. High indicator values signal a risk of asset overvaluation. By analyzing the projected P/E multiple of BioCryst (BCRX), one can determine a safe entry point.
Competitors of BioCryst (BCRX)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|veratx.com - Price to Future Earnings Ratio|Forward P/E Multiple DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Projected Price to Earnings Ratio|AbCellera Bio - Forward P/E Multiple|TRML: Future Price to Earnings|PGEN: Forward P/E Multiple|PHAR - Market Cap to Projected Earnings|Future Price to Earnings Nektar Therapeutics Inc.|Projected Price to Earnings Ratio Upstream Bio, Inc. UPB|Forward P/E Multiple ZBIO|Projected Price to Earnings Immunome Bio IMNM|Future Price to Earnings Gossamer Bio, Inc. GOSS|Future Price to Earnings Multiple KALV|SEPN: Projected Price to Earnings|Projected Price to Earnings Ratio Pieris Pharma|Savara Corp (SVRA) - Future Price to Earnings|RIGL - Market Cap to Projected Earnings|Projected Price to Earnings ANAB|ATXS (astriatx.com) - Market Cap to Future Earnings Ratio|Forward P/E Multiple ENGN|Future Price to Earnings RAPT (RAPT Therapeutics Inc.)|Forward P/E Multiple JBIO (Aerovate Therapeutics)|ACRS - Projected Price to Earnings|KYTX - Future Price to Earnings|Future Price to Earnings Multiple TLSA (tizianalifesciences.com)|CABA (Cabaletta Bio) - Projected Price to Earnings|Price to Future Earnings Ratio VTYX|Future Price to Earnings Theratechnologies Inc|Avalo Therapeutics Inc - Price to Expected Earnings Ratio|Forward P/E Multiple ELDN|AGEN (agenusbio.com) - Future Price to Earnings Multiple|Forward P/E Multiple CLYM (Climb Bio)|Forward P/E Multiple Zura Bio Ltd ZURA|ATYR - Future Price to Earnings|Future Price to Earnings Multiple ADAG (Adagene)|ikenaoncology.com (IMA) - Future Price to Earnings|Projected Price to Earnings Shattuck Labs|EQ (Equillium Inc) - Forward P/E Multiple|Forward P/E Multiple Connect Pharma|Projected Price to Earnings IMUX (Immunic, Inc.)|ATRA (atarabio.com) - Future Price to Earnings Multiple|Forward P/E Multiple IFRX (InflaRx)|Market Cap to Projected Earnings x4pharma.com (XFOR)|ACET - Future Price to Earnings|Celularity Inc. (CELU) - Projected Price to Earnings|INmune Bio Corp (INMB) - Future Price to Earnings|Projected Price to Earnings Barinthus Biotherapeutics Corp|Projected Price to Earnings KZR|Forward P/E Multiple sabbiotherapeutics.com|Future Price to Earnings Akari Therapeutics Plc (AKTX)|enlivex.com - Price to Future Earnings Ratio|Forward P/E Multiple QTTB (Q32 Bio)|GeoVax Corp (GOVX) - Projected Price to Earnings Ratio|Edesa Biotech, Inc. - Forward P/E Multiple|IBIO: Future Price to Earnings|CARM: Forward P/E Multiple|XTLB - Market Cap to Projected Earnings|Future Price to Earnings Bolt Biotherapeutics Inc.|Projected Price to Earnings Ratio HCW Biologics Inc HCWB|Forward P/E Multiple APVO|Projected Price to Earnings AIM ImmunoTech, Inc. AIM|Future Price to Earnings Aditxt, Inc. ADTX|Future Price to Earnings Multiple GRI|XRTX: Projected Price to Earnings|Projected Price to Earnings Ratio Vyome Therapeutics|Revelation Biosciences (REVB) - Future Price to Earnings|INDP - Market Cap to Projected Earnings|Projected Price to Earnings SCNI|CALI (CalciMedica Corp) - Market Cap to Future Earnings Ratio|Forward P/E Multiple AFMD|Future Price to Earnings ALLK (allakos.com)|Forward P/E Multiple HOOK (HOOKIPA Pharma)|IGMS - Projected Price to Earnings|ITOS - Future Price to Earnings|Future Price to Earnings Multiple OCEA (Ocean Biomedical Inc)|TCBP (TC BioPharm (Holdings) PLC) - Projected Price to Earnings|Price to Future Earnings Ratio THRD
